Stockscreener 앱 받기
6.36
4.22%
-0.28
전일 마감가:
$6.64
열려 있는:
$6.79
하루 거래량:
40,911
Relative Volume:
1.60
시가총액:
$57.53M
수익:
$23.84M
순이익/손실:
$-3.81M
주가수익비율:
-12.72
EPS:
-0.5
순현금흐름:
$-713.00K
1주 성능:
-2.08%
1개월 성능:
+5.30%
6개월 성능:
-1.55%
1년 성능:
+21.61%
1일 변동 폭
$6.27
$6.88
1주일 범위
$6.27
$6.88
52주 변동 폭
$4.28
$7.60
Immucell Corp Stock (ICCC) Company Profile
명칭
Immucell Corp
전화
(207) 878-2770
주소
56 EVERGREEN DR, PORTLAND, ME
ICCC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.36 | 60.06M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Immucell Corp 주식(ICCC)의 최신 뉴스
ImmuCell Corporation (NASDAQ:ICCC) Short Interest Update - MarketBeat
Aug Shorts: Is ImmuCell Corporation forming a bullish divergenceEarnings Overview Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Those who invested in ImmuCell (NASDAQ:ICCC) a year ago are up 25% - Yahoo Finance
ImmuCell Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement - Investing.com
Is ImmuCell Corporation stock resilient to inflationQuarterly Trade Summary & Precise Trade Entry Recommendations - Улправда
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense - Investing.com
Calf health company pauses one treatment to ramp a fast-growing product - Stock Titan
Macro Review: Is ImmuCell Corporation stock near bottom after declineJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - Улправда
How rising interest rates impact ImmuCell Corporation stockCPI Data & Daily Market Momentum Tracking - Улправда
Will ImmuCell Corporation stock maintain dividend yieldJuly 2025 Short Interest & Trade Opportunity Analysis Reports - Улправда
ImmuCell Corporation Announces Investor Conference Call to Discuss Strategic Shift and Q4 2025 Sales Results - Quiver Quantitative
Cattle firm ImmuCell shifts focus to calf product, previews 2025 sales - Stock Titan
The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - Stocktwits
ImmuCell Puts Re-Tain On Pause After FDA Letter - Benzinga
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio - sharewise.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Top Stock Reports for AbbVie, Coca-Cola & Chevron - sharewise.com
ImmuCell shifts focus to First Defense after FDA setback for Re-Tain By Investing.com - Investing.com South Africa
ImmuCell shifts focus to First Defense after FDA setback for Re-Tain - Investing.com
ImmuCell Corporation Receives Incomplete FDA Letter for Re-Tain® NADA and Expands First Defense® Sales Force by 50% - Quiver Quantitative
How a $900M calf-health market is reshaping this Maine animal company - Stock Titan
Will ImmuCell Corporation stock outperform Dow Jones indexJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - Улправда
Why ImmuCell Corporation stock is popular among millennialsQuarterly Market Review & Long-Term Capital Growth Strategies - Улправда
Can ImmuCell Corporation stock maintain operating marginsPortfolio Growth Summary & High Return Trade Guides - ulpravda.ru
ImmuCell Corporation's (NASDAQ:ICCC) Price Is Right But Growth Is Lacking After Shares Rocket 34% - simplywall.st
ImmuCell (NASDAQ:ICCC) Stock Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat
ImmuCell (NASDAQ:ICCC) delivers shareholders 27% return over 1 year, surging 13% in the last week alone - simplywall.st
Insider Buying: te Boekhorst Paul Francis Olivier Acquires Additional Shares of ImmuCell Corp (ICCC) - GuruFocus
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth - Finviz
Bull Run: Will ImmuCell Corporation stock maintain dividend yieldTrade Risk Report & Weekly Hot Stock Watchlists - moha.gov.vn
Will ImmuCell Corporation (IUL) stock benefit from sector leadershipJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
ImmuCell Corp President and CEO Acquires 9,785 Shares - TradingView — Track All Markets
Will ImmuCell Corporation stock continue dividend increasesMarket Sentiment Summary & Verified Technical Trade Signals - Newser
Will ImmuCell Corporation stock deliver consistent dividends2025 EndofYear Setup & Technical Confirmation Alerts - Newser
Is ImmuCell Corporation (IUL) stock a buy before earnings resultsJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser
Is ImmuCell Corporation (IUL) stock a fit for income portfoliosJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
ImmuCell (ICCC) director Tomsche buys shares worth $15,554 By Investing.com - Investing.com Canada
ImmuCell (ICCC) director Tomsche buys shares worth $15,554 - Investing.com
ImmuCell Corp Director David Scott Tomsche Buys Shares - TradingView
Chmn Tomsche Buys 3,266 ($15.6K) Of Immucell Corp [ICCC] - TradingView
ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Will ImmuCell Corporation stock sustain high P E ratiosM&A Rumor & Safe Investment Capital Preservation Plans - newser.com
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength - Yahoo Finance
Why ImmuCell Corporation stock is a must watch in 2025Trade Risk Report & Daily Profit Maximizing Tips - newser.com
Will ImmuCell Corporation bounce back from current supportJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
How to monitor ImmuCell Corporation with trend dashboards2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
Immucell Corp (ICCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Immucell Corp 주식 (ICCC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| te Boekhorst Paul Francis Oliv | President and CEO |
Dec 02 '25 |
Buy |
4.87 |
3,708 |
18,053 |
3,708 |
| Tomsche David Scott | Director |
Nov 25 '25 |
Buy |
4.76 |
1,633 |
7,781 |
4,740 |
| Tomsche David Scott | Director |
Nov 25 '25 |
Buy |
4.76 |
1,633 |
7,773 |
52,720 |
| Basse Gloria F | Director |
Jun 11 '25 |
Option Exercise |
4.81 |
3,530 |
16,979 |
3,530 |
4.73%
0.92%
자본화:
|
볼륨(24시간):